Stevens Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019
SELL
$94.77 - $215.54 $241,379 - $548,980
-2,547 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$207.3 - $300.31 $356,763 - $516,833
1,721 Added 208.35%
2,547 $545,000
Q2 2018

Aug 09, 2018
BUY
$101.55 - $313.9 $83,880 - $259,281
826 New
826 $231,000

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.35B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email